Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GREVE KIROPRAKTISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   3.0% 3.1% 2.6% 3.0% 2.5% 2.9% 19.2% 19.2%   Credit score (0-100)   59 57 61 56 62 58 7 7   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,398 1,448 1,311 1,458 1,226 1,381 0.0 0.0   EBITDA   465 642 511 592 372 445 0.0 0.0   EBIT   427 602 466 571 354 441 0.0 0.0   Pre-tax profit (PTP)   433.8 610.9 480.7 585.4 374.4 430.3 0.0 0.0   Net earnings   337.6 476.0 374.8 455.9 290.8 334.6 0.0 0.0   Pre-tax profit without non-rec. items   434 611 481 585 374 430 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   68.0 82.0 47.0 29.4 11.7 7.3 0.0 0.0   Shareholders equity total   466 612 512 593 429 474 18.8 18.8   Interest-bearing liabilities   0.0 0.0 64.9 421 534 553 0.0 0.0   Balance sheet total (assets)   702 863 917 1,299 1,223 1,256 18.8 18.8   Net Debt   -158 -190 60.2 411 529 548 -18.8 -18.8     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,398 1,448 1,311 1,458 1,226 1,381 0.0 0.0   Gross profit growth   0.3% 3.5% -9.4% 11.2% -15.9% 12.6% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   702 863 917 1,299 1,223 1,256 19 19   Balance sheet change%   6.1% 22.9% 6.2% 41.6% -5.8% 2.7% -98.5% 0.0%   Added value   465.0 641.7 510.7 591.5 374.1 445.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -56 -36 -90 -40 -35 -9 -7 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   30.5% 41.6% 35.5% 39.2% 28.9% 31.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   64.1% 79.0% 55.1% 55.0% 31.9% 38.7% 0.0% 0.0%   ROI %   94.7% 113.2% 79.2% 74.8% 40.6% 48.1% 0.0% 0.0%   ROE %   73.5% 88.4% 66.7% 82.5% 56.9% 74.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   66.3% 70.9% 55.8% 45.7% 35.1% 37.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -34.0% -29.6% 11.8% 69.4% 142.3% 123.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 12.7% 70.9% 124.3% 116.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1,014.9% 0.0% 29.5% 9.6% 5.8% 9.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 3.0 2.2 1.7 1.4 1.5 0.0 0.0   Current Ratio   2.4 3.0 2.2 1.7 1.5 1.5 0.0 0.0   Cash and cash equivalent   158.1 189.9 4.7 9.8 5.1 4.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   319.2 474.8 440.6 509.2 362.7 409.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   233 321 255 296 187 223 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   233 321 255 296 186 223 0 0   EBIT / employee   214 301 233 286 177 220 0 0   Net earnings / employee   169 238 187 228 145 167 0 0